Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) currently has a daily average trading volume of 1.89M but it saw 2840133 shares traded in last market. With a market cap of 1.04B USD, the company’s current market price of $4.12 came falling about -3.29 while comparing to the previous closing price of $4.26. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.56 and as low as $4.05. In the recent trading on the day, stock has struck highest price mark of $4.05 while lowest mark touched by it was $4.315.
Taking a look at 20-day trading activity of Maravai LifeSciences Holdings Inc (MRVI) gives us an average price of $4.92, while its current price level is -64.34% below from 52-week high level whereas it is 1.73% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.24 while that of 200 days or SMA-200 reads an average of $7.47. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.22% during that period while stretching the period over a month that decreases to 7.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.34 which implies that the stock is in neutral territory.
Goldman downgraded its recommendation for the stock as a “Sell” from “Neutral” on December 05, 2024 while assigning a price target of $4.25.
Over the week, MRVI’s stock price is moving -16.77% down while it is -9.25% when we observe its performance for the past one month. Year-to-date it is -24.40% down and over the past year, the stock is showing a downside performance of -25.09%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.04 while estimate for next year EPS is -0.08. In next quarter, company is expected to be making quarterly sales of $63.62M as analysts are expecting the sales for current fiscal year at $260.53M and seeing the company making $267.09M in sales next year. Moreover, analysts are in estimates of $57.79M for current-quarter revenue.
Currently, Maravai LifeSciences Holdings Inc’s total number of outstanding shares is 141.59M with 1.20% of that held by the insiders while 100.26% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -25.16% and return on equity (ROE) at -51.98%. Stock’s beta reads -0.07. Stock has a price to book (P/B) ratio of 1.69 while price to sale or P/S ratio amounts to 3.76. Its return on asset (ROA) is -12.67% on average.
